1.Study on early fibrinolytic therapy to avoid acute myocardial infarction.
Ji-gai LIU ; Yu-cai YAO ; Rui XU ; Wen-wei XU ; Wei ZHANG ; Rong-guang KUANG ; Mei GAO
Chinese Journal of Cardiology 2005;33(9):782-784
OBJECTIVETo investigate the frequency of aborted AMI and clinical characteristics of the patients received prompt fibrinolytic therapy.
METHODS1120 patients with AMI were divided into two groups, true AMI group and aborted AMI group. Aborted AMI was defined as maximal creatine kinase-MB < or = 2 x upper limit of normal coupled with the presence of resolution of chest pain and 50% of ST-segment deviation within 2 hours after onset of therapy. We compared some characteristic of two groups such as the fibrinolytic time after symptom onset and the frequency of aborted AMI.
RESULTSThe reopening ratio of infarct was 80.5%. 7.1% of the patients escaped myocardial necrosis. Aborted AMI was highest frequency within the first hour (22.0%) than other time groups (P < 0.01); There were no significant differences in the frequency of Aborted AMI in UK group, SK group and rt-PA group (7.0%, 6.7%, 7.1%, P > 0.05); The rate of Killip III/IV, major arrhythmias, angina pectoris and mortality at 30 day in aborted AMI patients compared with those who had true AMI was 3.9% versus 17.1%, 18.0% versus 30.0%, 1.3% versus 8.0%, 0 versus 6.0%, respectively (P < 0.01).
CONCLUSIONPrompt fibrinolytic therapy improved the likelihood of aborted AMI and clinical outcomes. The frequency of aborted AMI has no relationship with fibrinolytic drug, but closely related to the starting time of treatment from symptom onset.
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction ; drug therapy ; prevention & control ; Prognosis ; Thrombolytic Therapy
2.Association between the erythrocyte sedimentation rate, serum C-reactive protein and risk of lung cancer.
Yu-hui ZHANG ; Li-juan GUO ; Tu-guang KUANG ; Min ZHU ; Li-rong LIANG
Chinese Journal of Oncology 2010;32(1):48-51
OBJECTIVETo explore the association between the erythrocyte sedimentation rate, serum C-reactive protein (CRP) and the risk of lung cancer.
METHODSOne hundred and three patients with newly diagnosed lung cancer and 85 homochronous hospitalized patients with chronic respiratory diseases (including chronic obstructive pulmonary disease, asthma, bronchiectasis and pulmonary fibrosis) were included in this study. ESR, serum levels of CRP, CEA, CA19-9 and CA125 were analyzed in the two groups before the initiation of any therapy after hospitalization. The association with clinicopathological characteristics of lung cancer and the risk of lung cancer were estimated by logistic regression.
RESULTSBoth the ESR and CRP levels were significantly higher in the lung cancer group, as compared with that in the chronic respiratory diseases group (P < 0.001). There was no significant association of ESR and CRP with lung cancer stage and type. Spearman correlation analysis showed a positive correlation between ESR and CRP (r = 0.56, P < 0.001), ESR and CA125 (r = 0.33, P < 0.001), and CRP and CA125 (r = 0.32, P < 0.001). The results of multivariate logistic analysis showed that the level of CRP was associated with an increased risk of lung cancer. Adjusting the confounding factors such as age, gender and smoking condition, the risk increased along with the elevation of CRP. Compared with the first quantile patients, the risk of the second quantile patients increased twice (OR: 2.46, 95%CI: 1.16 - 5.20), the risk of the third quantile patients increased ten-fold (OR: 10.52, 95%CI: 4.40 - 25.18).
CONCLUSIONThe level of CRP is associated with an increased risk of lung cancer. The results of this study suggest that early detection of CRP may have a potential predicting value for high risk group of lung cancer.
Adenocarcinoma ; blood ; metabolism ; Adult ; Aged ; Blood Sedimentation ; C-Reactive Protein ; metabolism ; CA-125 Antigen ; metabolism ; Carcinoembryonic Antigen ; metabolism ; Carcinoma, Squamous Cell ; blood ; metabolism ; Chronic Disease ; Female ; Humans ; Logistic Models ; Lung Diseases ; blood ; metabolism ; Lung Neoplasms ; blood ; metabolism ; Male ; Membrane Proteins ; metabolism ; Middle Aged ; Neoplasm Staging ; Risk Factors ; Small Cell Lung Carcinoma ; blood ; metabolism